Fecal Transplants: a New Treatment for IBD

Linda Ann Sasser has had ulcerative colitis since she was 20, but it wasn’t until May 2019, about 30 years later, that her condition hit a low point: not only did she have a major flare-up of chronic inflammatory bowel disease (IBD), but on top of it, she had Clostridioides difficile (or C. diff), a highly contagious bacterial infection that causes severe diarrhea and inflammation of the colon. “I became really, really sick with bloody diarrhea 30 times a day and chronic stomach pain,” Sasser says. While hospitalized for 12 days, she was given oral steroid medications, which didn’t help, then IV steroid medications, which gradually improved her ulcerative colitis flare-up. The next challenge was to treat the C. diff infection. The doctors tried antibiotics, which didn’t get the job done; Sasser’s abdominal pain was incessant, and the diarrhea would come on so suddenly that she often couldn’t get to the bathroom in time. “I was at the point where I said, ‘Just take out my colon,’” she recalls. Her doctor told her about another treatment that might help: fecal microbiota transplantation (FMT), which is exactly what it sounds like: fecal matter (as in: stool) from a healthy donor is transplanted into the body of someone like Sasser in the hope that it will improve her health. [time-brightcove not-tgx=”true”] Sasser didn’t hesitate to opt in, because nothing else had worked for her, so she had FMT...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Disease feature Source Type: news

Related Links:

During her career, Debbie DiCarlo had worked for nonprofits dealing with immigration, foster case, sex trafficking and domestic violence, but she never saw herself working for a cancer organization. That is, until her best friend was diagnosed with cancer, and she subsequently moved to the Valley from California to do just that.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Hi, just started a practice at a hospital and much of what I'm seeing is Fibromyalgia + Opiates that other clinics do not want. My goal is to ramp up (as I'm setting 4-5 patients a day) with plans to build a more interventional practice. What advice do you have to try and achieve this?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pain Medicine Source Type: forums
20 years ago, dentistry was booming and it was the highest paid profession at $220K. My tuition was $5k a year, so it was a no brainer. This is the only job that saw wages decreased in 20 years. Now the avg dental salary is around $180k. Now, schools are charging over $100k a year. This is financial suicide. If I have to decide today, I would absolutely would not go into dentistry. Dental insurance companies are killing us. Year after year they are cutting fees. It’s tough being... Read more
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pre-Dental Source Type: forums
Too often, seniors who use opioids become targets for exploitation and abuse.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Drug Abuse and Traffic Drugs (Pharmaceuticals) Pain-Relieving Drugs Elderly Opioids and Opiates OxyContin (Drug) your-feed-health your-feed-healthcare Source Type: news
Shares of a Bay Area biotech company shot up more than 157% and another climbed to a lesser degree Friday after a Big Pharma company reported that a cancer drug with a shared target appeared effective in fighting tumors. Both Corvus Pharmaceuticals Inc. (Nasdaq: CRVS) of Burlingame and Arcus Biosciences Inc. (NYSE: RCUS) of Hayward shot up after AstraZeneca plc reported fresh data from a mid-stage clinical trial. That Big Pharma player said its already-approved cancer immunotherapy Imfinzi showed…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Koios Medical recently entered into a strategic partnership with GE Healthcar...Read more on AuntMinnie.comRelated Reading: AI can help classify masses found on breast ultrasound Koios secures FDA breakthrough designation for breast AI Koios Medical's AI for detecting breast cancer gets CE Mark Koios touts study on AI for breast biopsy FDA clears Koios Medical's breast cancer software
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
ConclusionThis study indicates that SIRT1 rs12778366 and rs4746720 may be genetic factors related to corticosteroid sensitivity in ITP patients.
Source: Annals of Hematology - Category: Hematology Source Type: research
This study aims to explore the effect of the ITI (interferon alpha-1b, thalidomide, and interleukin-2) regimen on the AML1-ETO fusion gene in patients with t(8;21) acute myeloid leukemia (AML) who were in hematologic remission but positive for the AML1-ETO fusion gene. From September 2014 to November 2020; 20 patients with AML (15 from The Affiliated Cancer Hospital of Zhengzhou University, 4 from The First Affiliated Hospital; and College of Clinical Medicine of Henan University of Science and Technology, and 1 from Anyang District Hospital) with hematological remission but AML1-ETO fusion gene positivity were treated wit...
Source: Annals of Hematology - Category: Hematology Source Type: research
AbstractWe investigated the feasibility and activity of an intensified dose-dense ABVD (dd-ABVD) regimen in patients with early-stage unfavorable Hodgkin lymphoma (HL). This prospective, multicenter, phase II study enrolled 96 patients with newly diagnosed, unfavorable stage I or II classical HL. The patients received four cycles of dd-ABVD followed by radiotherapy. Interim PET (PET-2) was mandatory after two courses. Primary endpoints were the evaluation of dd-ABVD feasibility and activity (incidence of PET-2 negativity). The feasibility endpoint was achieved with 48/52 (92.3%) patients receiving  >  85% ...
Source: Annals of Hematology - Category: Hematology Source Type: research
More News: Arthritis | Back Pain | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | China Health | Chronic Pain | Clinical Trials | Clostridium Difficile | Colon Cancer | Colonoscopy | Colorectal Cancer | Corticosteroid Therapy | Crohn's Disease | Depression | Diabetes | Diets | Eating Disorders & Weight Management | Endocrinology | Food and Drug Administration (FDA) | Gastric (Stomach) Cancer | Gastroenteritis | Gastroenterology | Genetics | Health | Heart | Hospitals | Infectious Diseases | Inflammatory Bowel Disease | Insulin | Irritable Bowel Syndrome | Metabolic Syndrome | Nasogastric Intubation | Nutrition | Obesity | Oral Cancer | Pain | Poisoning | Probiotics | Rheumatology | Science | Study | Transplants | Ulcerative Colitis | University of Minnesota